Tianjin Lisheng Pharmaceutical Co Ltd (002393) — Cash Flow Quality Index
Tianjin Lisheng Pharmaceutical Co Ltd (002393) has a Cash Flow Quality Index of 6.32x as of December 2025. Operating cash flow of CN¥287.81 Million exceeds net income of CN¥45.54 Million, indicating high earnings quality where cash backs reported profits. Explore Tianjin Lisheng Pharmaceutical Co Ltd cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Tianjin Lisheng Pharmaceutical Co Ltd Cash Flow Quality Index (2007–2025)
Historical Cash Flow Quality Index for Tianjin Lisheng Pharmaceutical Co Ltd across 19 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Tianjin Lisheng Pharmaceutical Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Tianjin Lisheng Pharmaceutical Co Ltd (2007–2025)
Year-by-year earnings quality comparison for Tianjin Lisheng Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see 002393 stock market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.09x | CN¥451.85 Million | CN¥416.28 Million | ▲ +126.9% |
| 2024 | 0.48x | CN¥88.26 Million | CN¥184.53 Million | ▼ -17.4% |
| 2023 | 0.58x | CN¥209.51 Million | CN¥361.83 Million | ▼ -83.6% |
| 2022 | 3.54x | CN¥331.38 Million | CN¥93.61 Million | ▲ +120.2% |
| 2021 | 1.61x | CN¥196.34 Million | CN¥122.11 Million | ▼ -81.9% |
| 2020 | 8.86x | CN¥76.37 Million | CN¥8.62 Million | ▲ +521.5% |
| 2019 | 1.43x | CN¥268.33 Million | CN¥188.14 Million | ▲ +62.2% |
| 2018 | 0.88x | CN¥162.69 Million | CN¥184.98 Million | ▼ -42.7% |
| 2017 | 1.53x | CN¥179.25 Million | CN¥116.82 Million | ▲ +2.2% |
| 2016 | 1.50x | CN¥173.60 Million | CN¥115.61 Million | ▼ -13.4% |
| 2015 | 1.73x | CN¥198.13 Million | CN¥114.22 Million | ▲ +123.0% |
| 2014 | 0.78x | CN¥72.24 Million | CN¥92.89 Million | ▼ -20.0% |
| 2013 | 0.97x | CN¥289.62 Million | CN¥298.06 Million | ▲ +16.9% |
| 2012 | 0.83x | CN¥250.72 Million | CN¥301.74 Million | ▲ +105.8% |
| 2011 | 0.40x | CN¥134.58 Million | CN¥333.39 Million | ▼ -52.6% |
| 2010 | 0.85x | CN¥186.55 Million | CN¥219.26 Million | ▼ -27.9% |
| 2009 | 1.18x | CN¥196.14 Million | CN¥166.25 Million | ▲ +33.7% |
| 2008 | 0.88x | CN¥126.59 Million | CN¥143.46 Million | ▼ -33.4% |
| 2007 | 1.33x | CN¥174.94 Million | CN¥131.95 Million | — |